Sanofi Ventures

Sanofi Ventures is the corporate venture capital arm of Sanofi, one of the world’s leading healthcare companies. The firm invests in early- to mid-stage biotech, digital health, and life sciences companies with innovative platforms and technologies that align with Sanofi’s core areas of interest. Sanofi Ventures provides strategic capital to entrepreneurs and companies transforming patient care through science and innovation.

Founded in 2016, Sanofi Ventures builds long-term partnerships with companies pioneering advancements in immunology, oncology, rare diseases, vaccines, and digital health. While financially driven, the firm operates with a strategic lens, supporting companies that complement Sanofi’s internal R&D and therapeutic goals. The investment team brings deep expertise in science, operations, and company-building.

Operating globally from offices in the U.S. and Europe, Sanofi Ventures backs visionary teams with the potential to create significant breakthroughs in healthcare. The firm typically participates in Seed, Series A, and Series B rounds, offering both capital and access to Sanofi’s global network, infrastructure, and expertise. With a collaborative approach, Sanofi Ventures helps portfolio companies navigate growth from concept to clinic.